Capital Fund Management S.A. Fulgent Genetics, Inc. Call Options Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$47.98 - $62.75 $604,548 - $790,650	12,600 New	12,600 $687,000
Q1 2022 May 12, 2022	SELL	$49.85 - $96.11 $1.55 Million - $2.99 Million	-31,100 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $1.7 Million - $2.31 Million	-22,000 Reduced 41.43%	31,100 $3.13 Million
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $2.64 Million - $3.9 Million	-35,200 Reduced 39.86%	53,100 $4.78 Million
Q2 2021 Aug 12, 2021	BUY	$66.8 - $100.45 $5.9 Million - $8.87 Million	88,300 New	88,300 $8.14 Million

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.